RefleXion Medical has formed a 10-member Scientific Advisory Board (SAB) that combines expertise in radiation oncology, medical oncology and nuclear medicine to expand patient treatment options. The new board will help guide unique treatment approaches for patients with all stages of cancer with the RefleXion X1, a platform designed with multidisciplinary cancer care in mind.
“The composition of our new SAB mirrors the clinical versatility of our system and reflects the multidisciplinary teamwork that characterizes modern cancer treatment,” said Sean Shirvani, MD, MPH, chief medical officer at RefleXion. “The board members will encourage rigorous thinking about the biology and treatment of advanced cancer with a breadth of clinical and technical knowledge that cuts across specialty boundaries and disease categories. These distinguished thought leaders bring impeccable research and clinical credentials to RefleXion’s overarching goal of improving the path forward for patients diagnosed with metastatic cancer.”
The founding members of the RefleXion Scientific Advisory Board are:
RefleXion Forms Scientific Advisory Board. Appl Rad Oncol.